Sara Murray, MD

HS Asst. Clinical Professor

Geriatrics, Hospital Medicine

Sara Murray, MD, MAS, is an Associate Professor of Clinical Medicine in the Division of Hospital Medicine at UCSF, and serves as Associate Chief Medical Information Officer for Inpatient Care and Data Science at UCSF Health. She also leads the Advanced Analytics and Innovation (A2I) team, using data science to transform care delivery in the health system.

M.A.S, 2017 - Clinical Research, University of California, San Francisco
Residency, 2014 - Internal Medicine, University of California, San Francisco
M.D., 2011 - Medicine, University of California, San Francisco
Cert, 2011 - Medicine (Certificate in Biomedical Research), University of California, San Francisco
  1. Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia.
  2. Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia.
  3. Restricting the Number of Open Patient Records in the Electronic Health Record: Is the Record Half Open or Half Closed?
  4. Automated and flexible identification of complex disease: building a model for systemic lupus erythematosus using noisy labeling.
  5. Using Spatial and Temporal Mapping to Identify Nosocomial Disease Transmission of Clostridium difficile.
  6. Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis.
  7. Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab.
  8. Cervical Spinal Fracture and Other Diagnoses Associated With Mortality in Hospitalized Ankylosing Spondylitis Patients.
  9. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.
  10. CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
  11. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
  12. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis.
  13. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.
  14. Iron control of erythroid development by a novel aconitase-associated regulatory pathway.
  15. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
  16. Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation.